// App-Quantinova.ai

209 : CK- and small nuclear size circulating tumor cell (CTCs) phenotypes in metastatic castration-resistant prostate cancer (mCRPC).

Researchers

Presenter

  • Roberta Ferraldeschi

Principal Investigators

  • Andrew McDaniel

  • Rachel Krupa

  • Scott A. Tomlins

  • Gerhardt Attard

  • Jessica Louw

  • Eric Tucker

  • Natalee Bales

  • Dena Marrinucci

  • Ruth Riisnaes

  • Joaquin Mateo

  • Ryan Dittamore

  • Johann Sebastian De Bono

Medical Centers

  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

  • Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI.

  • Epic Sciences, Inc., La Jolla, CA

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Phosphatase and tensin homolog

  • Circulating tumor cells

  • ETS transcription factor ERG

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved